Altered pressor responses in long-term nitrendipine treatment

Area of Science:

• Cardiovascular Pharmacology
• Hypertension Research
• Calcium Channel Blockers

Background:

• Hypertension is a prevalent cardiovascular condition.
• Norepinephrine (NE) and Angiotensin II (AII) are key regulators of blood pressure.
• Calcium entry blockers are a class of antihypertensive medications.

Purpose of the Study:

• To evaluate the long-term effects of nitrendipine on systemic pressor responses to NE and AII in patients with mild hypertension.
• To investigate the impact of nitrendipine on blood pressure and neurohormonal systems.

Main Methods:

• A double-blind, placebo-controlled study was conducted in 11 subjects with mild hypertension.
• Subjects received either nitrendipine (16 mg twice daily) or placebo for 5 weeks.
• Systemic pressor responses to NE and AII were measured before and after treatment.

Main Results:

• Nitrendipine significantly reduced clinic supine blood pressure.
• Pressor responses to NE were attenuated by nitrendipine, but responses to AII were not significantly affected.
• Endogenous plasma NE levels and renin activity remained unchanged with nitrendipine treatment.

Conclusions:

• Nitrendipine effectively lowers blood pressure in hypertensive individuals.
• Noradrenergic blood pressure control mechanisms appear more reliant on cellular calcium transport than AII-mediated pathways.
• These findings may explain the efficacy of calcium entry blockers in low-renin hypertension.